Market Introduction
This research report provides insights into the global wearable injectors market. Wearable injectors (WI) are drug delivery devices adhere to the body to deliver larger volumes of drug subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. WIs consists of reservoir for the medication, a cannula for delivery to the tissue, adhesive to fix the device to the patient’s skin, and a drive system to deliver the appropriate drug volume.
The scope of the wearable injectors market includes type, application, end user and region. The market for wearable injector is analyzed based on Europe region. The report offers insights and in-depth analysis of the wearable injectors market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Market Overview and Dynamics
The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system. However, the market is likely to have negative impact due to lack of adoption in emerging countries.
Key Market Segments
Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. The on-body injectors segment held the largest share of the market in 2019. However, the off-body injectors segment is estimated to register the highest CAGR of 13.0% in the market during the forecast period.
Based on application, the market is segmented into oncology, diabetes, autoimmune diseases, cardiovascular disease and other applications. The oncology segment held the largest share of the market in 2019. However, the autoimmune disease segment is estimated to register the highest CAGR of 13.4% in the market during the forecast period.
Based on end user, the market is segmented into homecare settings, hospital and clinical and other end users. The homecare setting segment held the largest share of the market in 2019. However, the hospitals and clinics segment is estimated to register the highest CAGR of 13.0% in the market during the forecast period.
Major Sources and Companies Listed
Some of the major primary and secondary sources for Asia Pacific Wearable Injectors market included in the report are, The National Center for Biotechnology Information, World Health Organization, Health Ministry of Japan, International Diabetes Federation, The Indian Council for Medical Research and others.
Reasons to buy the report
Asia Pacific Wearable Injectors Market –
By Application
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1160.40 Million |
| Market Size by 2027 | US$ 2939.97 Million |
| CAGR (2020 - 2027) | 12.4% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Wearable Injectors Market is valued at US$ 1160.40 Million in 2019, it is projected to reach US$ 2939.97 Million by 2027.
As per our report Asia Pacific Wearable Injectors Market, the market size is valued at US$ 1160.40 Million in 2019, projecting it to reach US$ 2939.97 Million by 2027. This translates to a CAGR of approximately 12.4% during the forecast period.
The Asia Pacific Wearable Injectors Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Wearable Injectors Market report:
The Asia Pacific Wearable Injectors Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Wearable Injectors Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Wearable Injectors Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)